Hutchens & Kramer Investment Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.79M Buy
5,658
+1,110
+24% +$1.13M 1.82% 14
2026
Q1
$4.18M Sell
4,548
-174
-4% -$176K 1.32% 15
2025
Q4
$5.07M Sell
4,722
-3,715
-44% -$3.55M 1.75% 11
2025
Q3
$6.44M Sell
8,437
-142
-2% -$106K 2.54% 8
2025
Q2
$6.66M Sell
8,579
-167
-2% -$130K 3.05% 7
2025
Q1
$7.22M Sell
8,746
-4,912
-36% -$4.09M 3.98% 4
2024
Q4
$10.5M Buy
13,658
+1,225
+10% +$1.01M 5.72% 3
2024
Q3
$11M Sell
12,433
-30,236
-71% -$27.2M 6.1% 3
2024
Q2
$39M Sell
42,669
-40
-0.1% -$32K 21.54% 1
2024
Q1
$32.5M Sell
42,709
-1,205
-3% -$858K 19.22% 1
2023
Q4
$25.6M Sell
43,914
-305
-0.7% -$178K 18.04% 1
2023
Q3
$23.8M Buy
44,219
+570
+1% +$294K 18.92% 1
2023
Q2
$20.5M Sell
43,649
-40
-0.1% -$16.8K 16.36% 1
2023
Q1
$15M Sell
43,689
-190
-0.4% -$64.1K 12.96% 1
2022
Q4
$16.1M Buy
43,879
+508
+1% +$180K 11.77% 1
2022
Q3
$13.9M Sell
43,371
-94
-0.2% -$29.8K 11.39% 2
2022
Q2
$14.1M Buy
43,465
+89
+0.2% +$26.7K 10.4% 1
2022
Q1
$12.7M Hold
43,376
7.05% 2
2021
Q4
$12.4M Buy
+43,376
New +$11M 7.81% 2

Other funds holding LLY

Hutchens & Kramer Investment Management Group's LLY Position: Q2 2026 in Review

Hutchens & Kramer Investment Management Group increased its Eli Lilly (LLY) stake by 24% in Q2 2026, buying an estimated $1.13M and bringing the position to 5,658 shares worth $6.79M. The position accounts for 1.82% of the portfolio, ranked #14.

Hutchens & Kramer Investment Management Group first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $39M in Q2 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hutchens & Kramer Investment Management Group held 5,658 shares of Eli Lilly worth $6.79M as of Q2 2026.
  • Hutchens & Kramer Investment Management Group bought 1,110 Eli Lilly shares in Q2 2026, an estimated $1.13M.
  • Eli Lilly made up 1.82% of Hutchens & Kramer Investment Management Group's portfolio in Q2 2026, its #14 holding.
  • Hutchens & Kramer Investment Management Group first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • Hutchens & Kramer Investment Management Group's Eli Lilly position peaked at $39M in Q2 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hutchens & Kramer Investment Management Group's 13F filing for Q2 2026, filed 9 Jul 2026.